Literature DB >> 34592511

Social cognition, neurocognition, symptomatology, functional competences and outcomes in people with schizophrenia - A network analysis perspective.

Michal Hajdúk1, David L Penn2, Philip D Harvey3, Amy E Pinkham4.   

Abstract

BACKGROUND: Extensive difficulties in reaching functional milestones characterize schizophrenia and related psychotic disorders. These impairments are in part explained by lower social cognitive abilities, cognitive impairment, and current psychopathology. The present study aims to model dynamic associations among social cognition, neurocognition, psychopathology, social skills, functional capacity, and functional outcomes in schizophrenia using network analysis in order to identify those factors that are most central to functioning.
METHODS: The sample consisted of 408 patients with schizophrenia spectrum disorders who were drawn from the SCOPE project. Participants completed a complex battery of state-of-the-art measures of social cognition, neurocognition, and functional outcomes. Gaussian Graphical Modeling was used for estimation of the network structure. Accuracy of the network was evaluated using the Bootstrap method.
RESULTS: Data supported the importance of functional capacity and social skills, which are prerequisites to real - world outcomes. These variables were among the most central in the network. Social cognition was related to functional capacity, social skills, and real - world functioning. Negative symptoms were connected to functional capacity, social skills, and real - world functioning.
CONCLUSIONS: Predictors of functional outcomes are complexly associated with each other. Functional capacity, social - skills, working memory, negative symptoms, mentalizing, and emotion recognition were central nodes that support their importance as potential targets of personalized intervention.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cognition; Competence; Functional outcomes; Network analysis; Schizophrenia; Social cognition

Mesh:

Year:  2021        PMID: 34592511      PMCID: PMC8665006          DOI: 10.1016/j.jpsychires.2021.09.041

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  39 in total

1.  The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity.

Authors:  Keith H Nuechterlein; Michael F Green; Robert S Kern; Lyle E Baade; Deanna M Barch; Jonathan D Cohen; Susan Essock; Wayne S Fenton; Frederick J Frese; James M Gold; Terry Goldberg; Robert K Heaton; Richard S E Keefe; Helena Kraemer; Raquelle Mesholam-Gately; Larry J Seidman; Ellen Stover; Daniel R Weinberger; Alexander S Young; Steven Zalcman; Stephen R Marder
Journal:  Am J Psychiatry       Date:  2008-01-02       Impact factor: 18.112

2.  Social cognition psychometric evaluation (SCOPE) in people with early psychosis: A preliminary study.

Authors:  Kelsey A Ludwig; Amy E Pinkham; Philip D Harvey; Skylar Kelsven; David L Penn
Journal:  Schizophr Res       Date:  2017-03-14       Impact factor: 4.939

Review 3.  The relationship between neurocognition and social cognition with functional outcomes in schizophrenia: a meta-analysis.

Authors:  Anne-Kathrin J Fett; Wolfgang Viechtbauer; Maria-de-Gracia Dominguez; David L Penn; Jim van Os; Lydia Krabbendam
Journal:  Neurosci Biobehav Rev       Date:  2010-07-08       Impact factor: 8.989

Review 4.  The functional significance of social cognition in schizophrenia: a review.

Authors:  Shannon M Couture; David L Penn; David L Roberts
Journal:  Schizophr Bull       Date:  2006-08-17       Impact factor: 9.306

5.  The positive and negative syndrome scale (PANSS) for schizophrenia.

Authors:  S R Kay; A Fiszbein; L A Opler
Journal:  Schizophr Bull       Date:  1987       Impact factor: 9.306

6.  Impaired introspective accuracy in schizophrenia: an independent predictor of functional outcomes.

Authors:  Juliet Silberstein; Philip D Harvey
Journal:  Cogn Neuropsychiatry       Date:  2018-11-26       Impact factor: 1.871

Review 7.  Pathways to functional outcomes in schizophrenia spectrum disorders: Meta-analysis of social cognitive and neurocognitive predictors.

Authors:  Tate F Halverson; Maku Orleans-Pobee; Carrington Merritt; Paschal Sheeran; Anne-Kathrin Fett; David L Penn
Journal:  Neurosci Biobehav Rev       Date:  2019-08-12       Impact factor: 8.989

Review 8.  The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10.

Authors:  D V Sheehan; Y Lecrubier; K H Sheehan; P Amorim; J Janavs; E Weiller; T Hergueta; R Baker; G C Dunbar
Journal:  J Clin Psychiatry       Date:  1998       Impact factor: 4.384

9.  Neuropsychological function and dysfunction in schizophrenia and psychotic affective disorders.

Authors:  Abraham Reichenberg; Philip D Harvey; Christopher R Bowie; Ramin Mojtabai; Jonathan Rabinowitz; Robert K Heaton; Evelyn Bromet
Journal:  Schizophr Bull       Date:  2008-05-20       Impact factor: 9.306

10.  Estimating psychological networks and their accuracy: A tutorial paper.

Authors:  Sacha Epskamp; Denny Borsboom; Eiko I Fried
Journal:  Behav Res Methods       Date:  2018-02
View more
  3 in total

1.  Differences of resting fMRI and cognitive function between drug-naïve bipolar disorder and schizophrenia.

Authors:  Jiaquan Liang; Wei Huang; Huagui Guo; Weibin Wu; Xiaoling Li; Caixia Xu; Guojun Xie; Wensheng Chen
Journal:  BMC Psychiatry       Date:  2022-10-21       Impact factor: 4.144

2.  Does Adding Social Cognitive Remediation Therapy to Neurocognitive Remediation Therapy Improve Outcomes in Young People With a Severe Mental Illness?-The Advantage Trial.

Authors:  Anthony W F Harris; Michelle Kightley; Joanna Williams; Cassandra Ma; Carlie Dodds
Journal:  Front Psychiatry       Date:  2022-03-14       Impact factor: 4.157

3.  Interplay among positive and negative symptoms, neurocognition, social cognition, and functioning in clinically stable patients with schizophrenia: a network analysis.

Authors:  Thammanard Charernboon
Journal:  F1000Res       Date:  2021-12-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.